Pub Date : 2023-02-15DOI: 10.15406/jcpcr.2023.14.00512
Luiz Eduardo Imbelloni, Bruno Basilio Cardoso, Claudia Carrada Torres, Geraldo Borges de Morais Filho, Sylvio Valença de Lemos Neto, Ana Cristina Pinho
{"title":"The anatomy of the thoracic spinal canal investigated with magnetic resonance imaging in children aged 0 to 13 years old","authors":"Luiz Eduardo Imbelloni, Bruno Basilio Cardoso, Claudia Carrada Torres, Geraldo Borges de Morais Filho, Sylvio Valença de Lemos Neto, Ana Cristina Pinho","doi":"10.15406/jcpcr.2023.14.00512","DOIUrl":"https://doi.org/10.15406/jcpcr.2023.14.00512","url":null,"abstract":"","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"66 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135681960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-12-27DOI: 10.15406/jcpcr.2021.12.00475
E. Kamperis, D. Dionysopoulos, K. Efthymiadis, C. Kodona, T. Zarampoukas, K. Hatziioannou, V. Giannouzakos
Multifocal gliomas comprise an uncommon clinical entity with challenging diagnostic and therapeutic ramifications. In this article, we present the case of a young man with progressive memory loss that was found to have numerous space-occupying lesions masquerading as secondary metastases in his brain MRI. Histopathological examination revealed a diffuse low-grade astrocytoma. The patient was successfully treated with radical chemoradiotherapy and adjuvant temozolomide and has been recurrence-free during three years of regular follow-up. While we review the contemporary diagnostic and therapeutic options, we emphasize the necessity of stereotactic biopsy to 1. exclude brain metastases, 2. provide tissue for further molecular characterization, which is helpful for prognostication, and 3. guide an individualized treatment plan. We also contend against using whole-brain radiotherapy based on its well-recognized detrimental neurocognitive effects and its inability to allow dose escalation. Instead, targeted radiotherapy with IMRT/VMAT should be the preferred irradiation technique. As our imaging technology advances, so does our ability to diagnose multifocal lesions that would have been classified as unifocal in the past. Hence, we expect that we will, more often, be finding ourselves confronted with this clinical scenario in the future.
{"title":"Multifocal low-grade astrocytoma successfully treated with volumetric modulated arc therapy and concurrent temozolomide","authors":"E. Kamperis, D. Dionysopoulos, K. Efthymiadis, C. Kodona, T. Zarampoukas, K. Hatziioannou, V. Giannouzakos","doi":"10.15406/jcpcr.2021.12.00475","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00475","url":null,"abstract":"Multifocal gliomas comprise an uncommon clinical entity with challenging diagnostic and therapeutic ramifications. In this article, we present the case of a young man with progressive memory loss that was found to have numerous space-occupying lesions masquerading as secondary metastases in his brain MRI. Histopathological examination revealed a diffuse low-grade astrocytoma. The patient was successfully treated with radical chemoradiotherapy and adjuvant temozolomide and has been recurrence-free during three years of regular follow-up. While we review the contemporary diagnostic and therapeutic options, we emphasize the necessity of stereotactic biopsy to 1. exclude brain metastases, 2. provide tissue for further molecular characterization, which is helpful for prognostication, and 3. guide an individualized treatment plan. We also contend against using whole-brain radiotherapy based on its well-recognized detrimental neurocognitive effects and its inability to allow dose escalation. Instead, targeted radiotherapy with IMRT/VMAT should be the preferred irradiation technique. As our imaging technology advances, so does our ability to diagnose multifocal lesions that would have been classified as unifocal in the past. Hence, we expect that we will, more often, be finding ourselves confronted with this clinical scenario in the future.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74003855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-12-06DOI: 10.15406/jcpcr.2021.12.00474
Jennifer Richardson, S. Serrano, Marco Luan
Hepatocellular carcinoma is one of the diagnoses that we most frequently see in our clinical practice, accustomed to seeing it as a single lesion, many do not know the diffuse subtype whose involvement and extension are rare. In this article, we present a case of diffuse hepatocarcinoma with cardiac extension and we discuss the importance of recognizing it because its management and prognosis depend on it.
{"title":"Diffuse hepatocellular carcinoma with extension into the right atrium","authors":"Jennifer Richardson, S. Serrano, Marco Luan","doi":"10.15406/jcpcr.2021.12.00474","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00474","url":null,"abstract":"Hepatocellular carcinoma is one of the diagnoses that we most frequently see in our clinical practice, accustomed to seeing it as a single lesion, many do not know the diffuse subtype whose involvement and extension are rare. In this article, we present a case of diffuse hepatocarcinoma with cardiac extension and we discuss the importance of recognizing it because its management and prognosis depend on it.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90108087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-11-25DOI: 10.15406/jcpcr.2021.12.00472
G. Fogarty, E. Paton, J. Allen, Julie Calvert, Tamara Dawson, Author Group of the Australian Keratinocyte Cancer Clinical Guidelines
{"title":"Towards better treatment outcomes for Australians with skin keratinocyte cancers - time for the patient voice?","authors":"G. Fogarty, E. Paton, J. Allen, Julie Calvert, Tamara Dawson, Author Group of the Australian Keratinocyte Cancer Clinical Guidelines","doi":"10.15406/jcpcr.2021.12.00472","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00472","url":null,"abstract":"","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"42 30","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91455768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-10-22DOI: 10.15406/jcpcr.2021.12.00471
Pedro G. Buiar, Marcela de Rezende Karnikowski
Colonoscopy is the most commonly performed method for Colon Cancer diagnosis and screening. And a successful exam requires bowel preparation. One of the main contraindications of the use of bowel cleansing agents is intestinal mechanical obstruction. But in many scenarios, as in public health services, there is a delay between the medical exam request and the data of the procedure. In some countries, this delay could be of many months. This interval is enough for nonobstructive colon cancer to turn into an obstructive lesion. The intake of bowel cleansing agents in an impending obstructive bowel syndrome could be a catastrophe. This is illustrated by this case report.
{"title":"A fatal complication of colonoscopy due to a stenotic colon cancer: an alert to colleagues","authors":"Pedro G. Buiar, Marcela de Rezende Karnikowski","doi":"10.15406/jcpcr.2021.12.00471","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00471","url":null,"abstract":"Colonoscopy is the most commonly performed method for Colon Cancer diagnosis and screening. And a successful exam requires bowel preparation. One of the main contraindications of the use of bowel cleansing agents is intestinal mechanical obstruction. But in many scenarios, as in public health services, there is a delay between the medical exam request and the data of the procedure. In some countries, this delay could be of many months. This interval is enough for nonobstructive colon cancer to turn into an obstructive lesion. The intake of bowel cleansing agents in an impending obstructive bowel syndrome could be a catastrophe. This is illustrated by this case report.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90188949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-10-20DOI: 10.15406/jcpcr.2021.12.00470
A. Lushnikova, A. V. Onyan, A. V. Kostarev, Ekaterina Yu. Rybalkina, Ksenia V Kohzikhova, S. Andreev
Background: Glioblastoma is very aggressive polymorphic brain tumor that is often chemo- and radio-resistant. This feature is related with glioma stem-like cells as well as with non-stem changeable cells from glioblastoma’s cell population. Search for molecular targets to overcome such resistance and to improve the effectiveness of therapy is one of the major challenges in applied molecular oncology. Objective: The aim of this study is to analyze a selective cytotoxicity of two cationic peptides (CPs) detected on two stable primary glioblastoma cell lines Glb0Sh and Glb-17. Induction of apoptosis in the cultures of recurrent glioblastoma cells and lack of cytotoxicity in normal cells was revealed by MTT assay, immunocytochemistry visualization of tumor cells after incubation with fluorescently labeled CP, RT PCR and western blotting. Results: We firstly confirm that chaperone proteins nucleolin/NCL and nucleophosmin/ NPM serve as cell molecular targets for CPs under study which has shown high selective cytotoxicity in two stable glioblastoma cell lines. These CPs are of interest for in vivo experiments as a promising anticancer agents.
{"title":"Induction of tumor cell apoptosis in human glioblastoma cell lines by cationic peptides","authors":"A. Lushnikova, A. V. Onyan, A. V. Kostarev, Ekaterina Yu. Rybalkina, Ksenia V Kohzikhova, S. Andreev","doi":"10.15406/jcpcr.2021.12.00470","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00470","url":null,"abstract":"Background: Glioblastoma is very aggressive polymorphic brain tumor that is often chemo- and radio-resistant. This feature is related with glioma stem-like cells as well as with non-stem changeable cells from glioblastoma’s cell population. Search for molecular targets to overcome such resistance and to improve the effectiveness of therapy is one of the major challenges in applied molecular oncology. Objective: The aim of this study is to analyze a selective cytotoxicity of two cationic peptides (CPs) detected on two stable primary glioblastoma cell lines Glb0Sh and Glb-17. Induction of apoptosis in the cultures of recurrent glioblastoma cells and lack of cytotoxicity in normal cells was revealed by MTT assay, immunocytochemistry visualization of tumor cells after incubation with fluorescently labeled CP, RT PCR and western blotting. Results: We firstly confirm that chaperone proteins nucleolin/NCL and nucleophosmin/ NPM serve as cell molecular targets for CPs under study which has shown high selective cytotoxicity in two stable glioblastoma cell lines. These CPs are of interest for in vivo experiments as a promising anticancer agents.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87721050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-09-28DOI: 10.15406/jcpcr.2021.12.00469
Jason Pannozzo, S. Vyas, G. Letterio, Harold A Matos-Casano, U. Bhatt, W. Cruz-Vetrano
Non-mucinous lepidic adenocarcinoma with pneumonic presentation is a rare form of lung cancer. Its ability to mimic infectious and inflammatory diseases in both patient presentation and diagnostic imaging can result in a delayed diagnosis. This case follows the workup of a 60-year-old non-smoker female who immigrated from Ecuador twenty years prior and worked at a shore repair shop for the past two years who presented with worsening shortness of breath and 15lbs weight loss over a two-month period. A unique aspect of this patient’s presentation was that the typical imaging and bronchoscopy findings often seen to distinguish this type of lung adenocarcinoma from other disease processes were absent. No nodular masses were observed on Computed Tomography (CT), and no lesions or airway abnormalities were seen on bronchoscopy. It was not until biopsy and bronchoalveolar lavage (BAL) that the diagnosis of adenocarcinoma was recognized. Our case aims to increase awareness among clinicians of the unpredictable presentation of nonmucinous lepidic adenocarcinoma. Furthermore, we want to highlight the relevance of including adenocarcinoma of the lung in the differential diagnosis even when infectious or occupational etiologies appear more likely.
{"title":"Non-mucinous adenocarcinoma: a unique case with a deceptive presentation","authors":"Jason Pannozzo, S. Vyas, G. Letterio, Harold A Matos-Casano, U. Bhatt, W. Cruz-Vetrano","doi":"10.15406/jcpcr.2021.12.00469","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00469","url":null,"abstract":"Non-mucinous lepidic adenocarcinoma with pneumonic presentation is a rare form of lung cancer. Its ability to mimic infectious and inflammatory diseases in both patient presentation and diagnostic imaging can result in a delayed diagnosis. This case follows the workup of a 60-year-old non-smoker female who immigrated from Ecuador twenty years prior and worked at a shore repair shop for the past two years who presented with worsening shortness of breath and 15lbs weight loss over a two-month period. A unique aspect of this patient’s presentation was that the typical imaging and bronchoscopy findings often seen to distinguish this type of lung adenocarcinoma from other disease processes were absent. No nodular masses were observed on Computed Tomography (CT), and no lesions or airway abnormalities were seen on bronchoscopy. It was not until biopsy and bronchoalveolar lavage (BAL) that the diagnosis of adenocarcinoma was recognized. Our case aims to increase awareness among clinicians of the unpredictable presentation of nonmucinous lepidic adenocarcinoma. Furthermore, we want to highlight the relevance of including adenocarcinoma of the lung in the differential diagnosis even when infectious or occupational etiologies appear more likely.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"116 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87767882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-08-30DOI: 10.15406/jcpcr.2021.12.00468
Anuhya Reddy M
Mucormycosis (formerly known as zygomycosis) is a severe but uncommon fungal disease characterized by a clan of moulds known as mucormycetes. These moulds may be found all over the place. Mucormycosis primarily affects those who have chronic illnesses or who use medications that decrease the body’s potential to exacerbate infections and infirmity. When individuals inhale fungal spores from the air, it most frequently affects the sinuses or lungs. Steroid usage, diabetes, and improper use of oxygen administration are all risk factors. This infection is characterized by headache, facial pain, nasal congestion, loss of vision or pain in the eyes, swelling in cheeks and eyes, black crests in the nose, coughing, and bloody vomits. Death occurs as a consequence of a lack of awareness of symptoms of Mucormycosis, high cost of therapy and the scarcity of medications, ignoring check-ups, and self-medication. Treatment of this devastating disease includes surgical excision of the involved part followed by antifungal therapy. While the rise of Mucormycosis in Covid instances is concerning, it is time for experts to work together to stop the spread of Mucormycosis. A solid referral and communication system among health professionals (e.g., pulmonologist, ENT surgeon, general physician, and maxillofacial dental surgeon) is the most important step in combating the disease in the current situation.
{"title":"Mucormycosis: An ignorance that cannot be ignored","authors":"Anuhya Reddy M","doi":"10.15406/jcpcr.2021.12.00468","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00468","url":null,"abstract":"Mucormycosis (formerly known as zygomycosis) is a severe but uncommon fungal disease characterized by a clan of moulds known as mucormycetes. These moulds may be found all over the place. Mucormycosis primarily affects those who have chronic illnesses or who use medications that decrease the body’s potential to exacerbate infections and infirmity. When individuals inhale fungal spores from the air, it most frequently affects the sinuses or lungs. Steroid usage, diabetes, and improper use of oxygen administration are all risk factors. This infection is characterized by headache, facial pain, nasal congestion, loss of vision or pain in the eyes, swelling in cheeks and eyes, black crests in the nose, coughing, and bloody vomits. Death occurs as a consequence of a lack of awareness of symptoms of Mucormycosis, high cost of therapy and the scarcity of medications, ignoring check-ups, and self-medication. Treatment of this devastating disease includes surgical excision of the involved part followed by antifungal therapy. While the rise of Mucormycosis in Covid instances is concerning, it is time for experts to work together to stop the spread of Mucormycosis. A solid referral and communication system among health professionals (e.g., pulmonologist, ENT surgeon, general physician, and maxillofacial dental surgeon) is the most important step in combating the disease in the current situation.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86175217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-08-19DOI: 10.15406/jcpcr.2021.12.00467
Manoel Pereira da Silva Junior, Michelly de Oliveira Leopoldino, Fernanda Silva Monteiro, Ana Paula Miyazawa
For the oncology patient in palliative care, talking about the process of death and dying can cause discomfort, because, in addition to insecurity about their future, it can awaken a negative feeling that influences the way the patient and his family deal with the situation imposed by illness. The aim of this study was to discuss the role of spirituality in coping with death in patients under palliative care. This is a descriptive, exploratory study with a qualitative approach carried out through a literature review. A search was carried out in the sources of concepts and principles: National Palliative Care Agency-ANCP and the National Cancer Institute-INCA, as well as research in Scientifc Eletronic Library Online (Scielo), in the databases, in the virtual health library (VHL) ) and Latin American in Health Sciences (LILACS) in the period from July to November 2019. One can experience spirituality even though conceptualizing it as atheism, as the search for spirituality does not necessarily mean a search for God. This demonstrates how spirituality has a particular and subjective character, without having to follow absolute truths imposed by religions. Ignoring the spiritual dimension makes the patient’s approach incomplete because it puts the focus of care centered on the disease. It is concluded that the humanization of palliative care for cancer patients must go further, contemplating the patient’s spiritual issues, since the concern and questions about death take on a greater proportion when physical symptoms are no longer a challenge to be addressed. overcome, but rather, the fear of the unknown before the prospect of death.
{"title":"Spirituality in addressing death in oncological patients in palliative care","authors":"Manoel Pereira da Silva Junior, Michelly de Oliveira Leopoldino, Fernanda Silva Monteiro, Ana Paula Miyazawa","doi":"10.15406/jcpcr.2021.12.00467","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00467","url":null,"abstract":"For the oncology patient in palliative care, talking about the process of death and dying can cause discomfort, because, in addition to insecurity about their future, it can awaken a negative feeling that influences the way the patient and his family deal with the situation imposed by illness. The aim of this study was to discuss the role of spirituality in coping with death in patients under palliative care. This is a descriptive, exploratory study with a qualitative approach carried out through a literature review. A search was carried out in the sources of concepts and principles: National Palliative Care Agency-ANCP and the National Cancer Institute-INCA, as well as research in Scientifc Eletronic Library Online (Scielo), in the databases, in the virtual health library (VHL) ) and Latin American in Health Sciences (LILACS) in the period from July to November 2019. One can experience spirituality even though conceptualizing it as atheism, as the search for spirituality does not necessarily mean a search for God. This demonstrates how spirituality has a particular and subjective character, without having to follow absolute truths imposed by religions. Ignoring the spiritual dimension makes the patient’s approach incomplete because it puts the focus of care centered on the disease. It is concluded that the humanization of palliative care for cancer patients must go further, contemplating the patient’s spiritual issues, since the concern and questions about death take on a greater proportion when physical symptoms are no longer a challenge to be addressed. overcome, but rather, the fear of the unknown before the prospect of death.","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87996797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-08-13DOI: 10.15406/jcpcr.2021.12.00466
Joseph R. Malhis, S. O'Brien, R. Vasanwala, Kerry J Williams-Wuch
{"title":"Case of inherited epidermal growth factor receptor (EGFR) in non-small cell lung carcinoma (NSCLC) in a 37-year-old male ","authors":"Joseph R. Malhis, S. O'Brien, R. Vasanwala, Kerry J Williams-Wuch","doi":"10.15406/jcpcr.2021.12.00466","DOIUrl":"https://doi.org/10.15406/jcpcr.2021.12.00466","url":null,"abstract":"","PeriodicalId":15185,"journal":{"name":"Journal of Cancer Prevention & Current Research","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82391500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：